Diphenoxylate therapy for psoriasis.

Diphenoxylate therapy for psoriasis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Diphenoxylate therapy for psoriasis. Abstract Text:

Diphenoxylate therapy for psoriasis. Publishing Authors By Initials

For similar skin and connective tissue diseases: skin diseases: skin diseases, papulosquamous: psoriasis research abstracts see: skin and connective tissue diseases: skin diseases: skin diseases, papulosquamous: psoriasis research

PUBMED ID PMID:

MEDLINE DATE:

Diphenoxylate therapy for psoriasis. Journal Published:

PUBLICATION TYPE: Letter

Journal: Archives of dermatology

VOLUME: 121

Page Numbers: 1486

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Dec

YEAR: 1985

Diphenoxylate therapy for psoriasis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Diphenoxylate therapy for psoriasis. Keywords Mesh Terms:

KEYWORDS: Psoriasis

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Diphenoxylate therapy for psoriasis. Information

Substance Name: Diphenoxylate

Registry Number: 915-30-0

Grant and Affiliation Information for Diphenoxylate therapy for psoriasis.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Diphenoxylate therapy for psoriasis Related Publications

• 2008 legislative session preview.
• Activator of g protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.
• Back to the future--defining NK cells and T cells.
• Basic diphenoxylate therapy.
• Children's expectations of pain, perceptions of analgesic efficacy, and experiences with nonpharmacologic pain management strategies at home following tonsillectomy.
• Classifying the severity of corneal ulcers by using the "1, 2, 3" rule.
• DAP12: an adapter protein with dual functionality.
• Development, implementation, and evaluation of a computerized self-administered diet history questionnaire for use in studies of american Indian and alaskan native people.
• Diphenoxylate therapy for psoriasis.
• Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.
• Disseminated intravascular coagulation after craniotomy.
• Evaluation of a self-instructional training program for simulated patients.
• Evolutionary struggles between NK cells and viruses.
• Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells.
• Improving the art and science of disaster medicine and public health preparedness.
• Injuries to the bowel as the result of an enema.
• Letters to the editor.
• Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
• Mature and well-thought out plan.
• Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling.
• NK cell receptors.
• NK cell recognition of mouse cytomegalovirus-infected cells.
• Neuroanesthesiology review-2007.
• Scale-dependence of Cope's rule in body size evolution of Paleozoic brachiopods.
• The G-protein regulatory (GPR) motif-containing Leu-Gly-Asn-enriched protein (LGN) and Gialpha3 influence cortical positioning of the mitotic spindle poles at metaphase in symmetrically dividing mammalian cells.
• The proto-oncogene SET interacts with muscarinic receptors and attenuates receptor signaling.
• The psychological and social sciences in the national military establishment.
• Up on the tightrope: natural killer cell activation and inhibition.
• Use of intranasal corticosteroids in the management of congestion and sleep disturbance in pediatric patients with allergic rhinitis.
• Virus-driven evolution of natural killer cell receptors.